The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases
Open accessAbstract
Enhanced and premature atherosclerosis is a feature of some AIRDs and a possible feature of others because of inflammation and more specific immune mechanisms (Table 3). RA, SLE, and APS carry an increased risk for CVD. RA and SLE are characterized by an increased risk of coronary artery disease and prevalence of typical risk factors for these diseases and an increased extent of subclinical atherosclerosis. However, other factors attributed to disease activity, inflammation, and therapeutic interventions are also implicated in the higher prevalence of atherosclerosis and its complications in both diseases. APS is a prothrombotic statecharacterized by thrombosis of any vessel; however, the association of aPL with CVDs in the general population, the findings of enhanced subclinical atherosclerosis in APS patients, and the proatherogenic effect of aPL in animal models support a possible proatherogenic (in addition to prothrombotic) role of these autoantibodies. In these 3 conditions, premature atherosclerosis can be detected in some patients in its preclinical stage. Physicians thus should attempt to minimize the presence of conventional CVD risk factors in their patients and treat their patients as belonging to a group having a high risk for CVD. In SSc and PSV, although there is a high prevalence of macrovascular disease, there are few data supporting enhanced atherosclerosis in these conditions. In addition, no data yet exist to support enhanced atherosclerosis in SS. Future research is needed to determine whether these AIRDs are also associated with accelerated atherosclerosis and its manifestations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Manzi, S., Meilahn, E. N., Rairie, J. E., Conte, C. G., Medsger, T. A., Jansen-McWilliams, L., D'Agostino, R. B., & Kuller, L. H. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009122 · Cited by 1,834
Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Roman, M. J., Shanker, B.-A., Davis, A., Lockshin, M. D., Sammaritano, L., Simantov, R., Crow, M. K., Schwartz, J. E., Paget, S. A., Devereux, R. B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035471 · Cited by 1,427
Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis
Solomon, D. H., Karlson, E. W., Rimm, E. B., Cannuscio, C. C., Mandl, L. A., Manson, J. E., Stampfer, M. J., & Curhan, G. C. (2003) · Circulation · doi:10.1161/01.cir.0000054612.26458.b2 · Cited by 1,246
Lumeij, J. T. (1997) · Clinical Biochemistry of Domestic Animals · doi:10.1016/b978-012396305-5/50031-2 · Cited by 1,163
The bimodal mortality pattern of systemic lupus erythematosus
Urowitz, M. B., Bookman, A. A. M., Koehler, B. E., Gordon, D. A., Smythe, H. A., & Ogryzlo, M. A. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90431-9 · Cited by 1,000
Cardiovascular death in rheumatoid arthritis: A population‐based study
Maradit‐Kremers, H., Nicola, P. J., Crowson, C. S., Ballman, K. V., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20878 · Cited by 934
Premature Coronary-Artery Atherosclerosis in Systemic Lupus Erythematosus
Asanuma, Y., Oeser, A., Shintani, A. K., Turner, E., Olsen, N., Fazio, S., Linton, M. F., Raggi, P., & Stein, C. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035611 · Cited by 892
Risk factors for coronary artery disease in patients with systemic lupus erythematosus
Petri, M., Perez-Gutthann, S., Spence, D., & Hochberg, M. C. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90578-y · Cited by 624
Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis?
Van Doornum, S., McColl, G., & Wicks, I. P. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10089 · Cited by 606
Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus
Manzi, S., Selzer, F., Sutton-Tyrrell, K., Fitzgerald, S. G., Rairie, J. E., Tracy, R. P., & Kuller, L. H. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199901)42:1<51::aid-anr7>3.0.co;2-d · Cited by 559
Zhou, X., Nicoletti, A., Elhage, R., & Hansson, G. K. (2000) · Circulation · doi:10.1161/01.cir.102.24.2919 · Cited by 554
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes.
Liuzzo, G., Goronzy, J. J., Yang, H., Kopecky, S. L., Holmes, D. R., Frye, R. L., & Weyand, C. M. (2000) · Circulation · doi:10.1161/01.cir.101.25.2883 · Cited by 552
Risk Factors for Cardiovascular Disease in Systemic Lupus Erythematosus
Svenungsson, E., Jensen-Urstad, K., Heimbürger, M., Silveira, A., Hamsten, A., de Faire, U., Witztum, J. L., & Frostegård, J. (2001) · Circulation · doi:10.1161/hc4101.097518 · Cited by 500
Cervera, R., Khamashta, M. A., Font, J., Sebastiani, G. D., Gil, A., Lavilla, P., Aydintug, A. O., Jedryka-Góral, A., Ramón, E. D., Fernández-Nebro, A., et al. (1999) · Medicine · doi:10.1097/00005792-199905000-00003 · Cited by 430
Vaarala, O., Aho, K., Palosuo, T., Alfthan, G., Jauhiainen, M., & Leirisalo-Repo, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)91213-6 · Cited by 409
Doria, A., Shoenfeld, Y., Wu, R., Gambari, P. F., Puato, M., Ghirardello, A., Gilburd, B., Corbanese, S., Patnaik, M., Zampieri, S., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.11.1071 · Cited by 403
Self-citationdel Rincón, I., Williams, K., Stern, M. P., Freeman, G. L., O'Leary, D. H., & Escalante, A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11078 · Cited by 353
Outcome in Systemic Lupus Erythematosus: A Prospective Study of Patients from a Defined Population
JONSSON, H., NIVED, O., & STURFELT, G. (1989) · Medicine · doi:10.1097/00005792-198905000-00002 · Cited by 314
Kumeda, Y., Inaba, M., Goto, H., Nagata, M., Henmi, Y., Furumitsu, Y., Ishimura, E., Inui, K., Yutani, Y., Miki, T., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10269 · Cited by 313
Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?
Vallance, P., Collier, J., & Bhagat, K. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09424-x · Cited by 308
Predisposition to Atherosclerosis by Infections: Role of Endothelial Dysfunction
Prasad, A., Zhu, J., Halcox, J. P. J., Waclawiw, M. A., Epstein, S. E., & Quyyumi, A. A. (2002) · Circulation · doi:10.1161/01.cir.0000021125.83697.21 · Cited by 308
OutiVaarala, MattiMänttäri, VesaManninen, LeenaTenkanen, MarjaPuurunen, KimmoAho, & TimoPalosuo (1995) · Circulation · Cited by 305
Bergmark, C., Wu, R., Faire, U. D., Lefvert, A. K., & Swedenborg, J. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.4.441 · Cited by 280
Anticardiolipin antibodies are an independent risk factor for first ischemic stroke
The Antiphospholipid Antibodies in Stroke Study (APASS) Group (1993) · Neurology · doi:10.1212/wnl.43.10.2069 · Cited by 267
Manoussakis, M. N., Georgopoulou, C., Zintzaras, E., Spyropoulou, M., Stavropoulou, A., Skopouli, F. N., & Moutsopoulos, H. M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20093 · Cited by 255
CD4+CD28− T Lymphocytes Contribute to Early Atherosclerotic Damage in Rheumatoid Arthritis Patients
Gerli, R., Schillaci, G., Giordano, A., Bocci, E. B., Bistoni, O., Vaudo, G., Marchesi, S., Pirro, M., Ragni, F., Shoenfeld, Y., et al. (2004) · Circulation · doi:10.1161/01.cir.0000131450.66017.b3 · Cited by 254
Self-citationAtherosclerosis in rheumatoid arthritis: Morphologic evidence obtained by carotid ultrasound
Park, Y., Ahn, C., Choi, H. K., Lee, S., In, B., Lee, H., Nam, C., & Lee, S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10359 · Cited by 249
LeRoy, E. C. (1996) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70295-7 · Cited by 240
PETRI, M., SPENCE, D., BONE, L. R., & HOCHBERG, M. C. (1992) · Medicine · doi:10.1097/00005792-199209000-00004 · Cited by 234
Selzer, F., Sutton‐Tyrrell, K., Fitzgerald, S. G., Pratt, J. E., Tracy, R. P., Kuller, L. H., & Manzi, S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11418 · Cited by 229
Impaired Responsiveness to NO in Newly Diagnosed Patients With Rheumatoid Arthritis
Bergholm, R., Leirisalo-Repo, M., Vehkavaara, S., Mäkimattila, S., Taskinen, M.-R., & Yki-Järvinen, H. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000033516.73864.4e · Cited by 214
Atherosclerosis, autoimmunity, and vascular‐associated lymphoid tissue
Wick, G., Romen, M., Amberger, A., Metzler, B., Mayr, M., Falkensammer, G., & Xu, Q. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.13.9367355 · Cited by 197
George, J., Harats, D., Gilburd, B., Afek, A., Shaish, A., Kopolovic, J., & Shoenfeld, Y. (2000) · Circulation · doi:10.1161/01.cir.102.15.1822 · Cited by 167
Self-citationHeat-Shock Protein 60-Reactive CD4 + CD28 null T Cells in Patients With Acute Coronary Syndromes
Zal, B., Kaski, J. C., Arno, G., Akiyu, J. P., Xu, Q., Cole, D., Whelan, M., Russell, N., Madrigal, J. A., Dodi, I. A., et al. (2004) · Circulation · doi:10.1161/01.cir.0000118476.29352.2a · Cited by 164
Accelerated atherosclerosis in patients with Wegener's granulomatosis
de Leeuw, K., Sanders, J.-S., Stegeman, C. A., Smit, A. J., Kallenberg, C. G., & Bijl, M. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.029033 · Cited by 146
Are Anti–Oxidized Low-Density Lipoprotein Antibodies Pathogenic or Protective?
Shoenfeld, Y., Wu, R., Dearing, L. D., & Matsuura, E. (2004) · Circulation · doi:10.1161/01.cir.0000143225.07377.ea · Cited by 146
Self-citationBlood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis
Matucci‐Cerinic, M., Valentini, G., Sorano, G. G., D’Angelo, S., Cuomo, G., Fenu, L., Generini, S., Cinotti, S., Morfini, M., Pignone, A. M., et al. (2003) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.50011 · Cited by 145
Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome
Jiménez, S., García‐Criado, Á., Tàssies, D., Reverter, J. C., Cervera, R., Gilabert, M. R., Zambón, D., Ros, E., Brú, C., & Font, J. (2005) · Rheumatology · doi:10.1093/rheumatology/keh581 · Cited by 143
Papa, N. D., Guidali, L., Sironi, M., Shoenfeld, Y., Mantovani, A., Tincani, A., Balestrieri, G., Radice, A., Sinico, R. A., & Meroni, P. L. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390507 · Cited by 138
Self-citationAtherosclerosis as an infectious, inflammatory and autoimmune disease
Shoenfeld, Y., Sherer, Y., & Harats, D. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01922-6 · Cited by 135
Self-citationLockshin, M. D., Tenedios, F., Petri, M., McCarty, G. A., Forastiero, R. R., Krilis, S. A., Tincani, A., Erkan, D., Khamashta, M. A., & Shoenfeld, Y. (2003) · Lupus · doi:10.1191/0961203303lu391oa · Cited by 129
Self-citationAutoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus
Reichlin, M., Fesmire, J., Quintero‐Del‐Rio, A. I., & Wolfson‐Reichlin, M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10624 · Cited by 127
Vlachoyiannopoulos, P. G. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keg182 · Cited by 117
Ames, P. R. J., Margarita, A., Alves, J. D., Tommasino, C., Iannaccone, L., & Brancaccio, V. (2002) · Lupus · doi:10.1191/0961203302lu165oa · Cited by 117
Medina, G., Casaos, D., Jara, L. J., Vera-Lastra, O., Fuentes, M., Barile, L., & Salas, M. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.7.607 · Cited by 114
Self-citationBruce, I. N., Burns, R. J., Gladman, D., & Mb, U. (2000) · PubMed · Cited by 98
Wu, R., & Lefvert, A. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb06652.x · Cited by 94
Antiinflammatory and Immunomodulatory Properties of Statins
Shovman, O., Levy, Y. M., Gilburd, B., & Shoenfeld, Y. (2002) · Immunologic Research · doi:10.1385/ir:25:3:271 · Cited by 86
Self-citationAlves, J. D., Kumar, S., & Isenberg, D. A. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keg248 · Cited by 86
Fatini, C., Gensini, F., Sticchi, E., Battaglini, B., Angotti, C., Conforti, M. L., Generini, S., Pignone, A. M., Abbate, R., & Matucci‐Cerinic, M. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01069-0 · Cited by 78
Is fibromyalgia a generalized reflex sympathetic dystrophy?
Martínez‐Lavín, M. (2001) · PubMed · Cited by 74
Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE
Wu, R., Svenungsson, E., Gunnarsson, I., Andersson, B., Lundberg, I. E., Elinder, L. S., & Frostegård, J. (1999) · Lupus · doi:10.1191/096120399678847434 · Cited by 70
Soltész, P., Veres, K., Lakos, G., Kiss, E. V., Muszbek, L., & Szegedi, G. (2003) · Lupus · doi:10.1191/0961203303lu339oa · Cited by 70
Hornung, N., Ellingsen, T., Stengaard‐Pedersen, K., & Poulsen, J. H. (2004) · PubMed · Cited by 62
Alves, J. D., & Grima, B. (2003) · Current Rheumatology Reports · doi:10.1007/s11926-003-0029-1 · Cited by 58
Oxidative stress in Systemic Sclerosis
Simonini, G., Matucci‐Cerinic, M., Generini, S., Zoppi, M., Anichini, M., Cesaretti, C., Pignone, A. M., Falcini, F., Lotti, T., & Cagnoni, M. (1999) · Springer eBooks · doi:10.1007/978-1-4615-5097-6_10 · Cited by 57
Lopez, D., Kobayashi, K., Merrill, J. T., Matsuura, E., & Lopez, L. R. (2003) · Journal of Immunology Research · doi:10.1080/10446670310001642113 · Cited by 53
Self-citationStaub, H. L., Norman, G. L., Crowther, T. M., da Cunha, V. R., Polanczyk, A., Bohn, J. M., Fernandes, J. G., Chahade, W. H., & von Mühlen, C. A. (2003) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2003000500010 · Cited by 52
New evidence for vascular disease in patients with early rheumatoid arthritis
Kaplan, M. J., & McCune, W. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12901-7 · Cited by 45
Patients with systemic vasculitis have increased levels of autoantibodies against oxidized LDL
Swets, B. P., Dijck-Brouwer, J., & Tervaert, J. W. C. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01488.x · Cited by 38
The Autoimmune Pathogenesis of Atherosclerosis—An Evolutionary-Darwinian Concept
Wick, G., Millonig, G., & Xu, Q. (2001) · Elsevier eBooks · doi:10.1016/b978-044450669-6/50003-7 · Cited by 15
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
Tyndall, A. J., Bannert, B., Vonk, M., Airò, P., Cozzi, F., Carreira, P. E., Bancel, D. F., Allanore, Y., Müller-Ladner, U., Distler, O., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.114264 · Cited by 1,443
Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
Précoma, D. B., Oliveira, G. M. M. D., Simão, A. F., Dutra, O. P., Coelho-Filho, O. R., Izar, M. C. D. O., Póvoa, R. M. D. S., Giuliano, I. D. C. B., Alencar Filho, A. C. D., Machado, C. A., et al. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190204 · Cited by 434
Gonzalez‐Gay, M. A., Gonzalez‐Juanatey, C., Lopez‐Diaz, M. J., Piñeiro, A., Garcia‐Porrua, C., Miranda‐Filloy, J. A., Ollier, W. E. R., Martin, J., & Llorca, J. (2007) · Arthritis Care & Research · doi:10.1002/art.22482 · Cited by 363
Schreiber, K., Sciascia, S., de Groot, P. G., Devreese, K., Jacobsen, S., Ruiz-Irastorza, G., Salmon, J. E., Shoenfeld, Y., Shovman, O., & Hunt, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.103 · Cited by 359
Self-citationMechanisms of Disease: atherosclerosis in autoimmune diseases
Sherer, Y., & Shoenfeld, Y. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0092 · Cited by 357
Self-citation
Metadata
- Authors
- Shoenfeld, Y., Gerli, R., Doria, A., Matsuura, E., Cerinic, M. M., Ronda, N., Jara, L. J., Abu-Shakra, M., Meroni, P. L., & Sherer, Y.
- Venue
- Circulation
- Published
- 2005-11-22
- Volume
- 112
- Issue
- 21
- Pages
- 3337-3347
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2039093757
- Cited by
- 555
- References
- 64
- FWCI
- 17.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.